scPharmaceuticals Competitors and Similar CompaniesClear all
scPharmaceuticals's competitors and similar companies include Oxurion.
 scPharmaceuticals scPharmaceuticals, a biopharmaceutical company, develops a portfolio of transformative pharmaceutical products for subcutaneous delivery. |  Oxurion Oxurion (formerly known as ThromboGenics) is a biopharmaceutical company developing treatments to preserve vision in patients with diseases affecting the back of the eye. | |
Founding Date | Founding Date 2014 | Founding Date 1991 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Burlington, US HQ | Locations Leuven, BE HQ Dublin 8, IE |
Employees | Employees 96256% increase | Employees 785% increase |
Valuation ($) | Valuation ($) 221.6 m | Valuation ($) 626.1 k |
Financial | ||
Revenue (est.) | Revenue (est.) $36.3m (FY, 2024) | Revenue (est.) €555k (FY, 2025) |
Cost of goods | Cost of goods $11.4m (FY, 2024) | Cost of goods N/A |
Gross profit | Gross profit $25m (FY, 2024) | Gross profit €937k (FY, 2025) |
Net income | Net income ($85.1m) (FY, 2024) | Net income (€3.7m) (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 62.5m | Total funding raised $ 3.9m |
For sources of this data, please see the company profile
View Company Profiles
Oxurion
HQ
Leuven, BE
Employees
78↑ 5% increase
Oxurion (formerly known as ThromboGenics) is a biopharmaceutical company developing treatments to preserve vision in patients with diseases affecting the back of the eye.
View company